assubex 15 mg, assubex 20 mg
egis pharmaceuticals plc, maďarsko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
assubex 20 mg
egis pharmaceuticals plc, maďarsko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
assubex 15 mg
egis pharmaceuticals plc, maďarsko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
assubex 10 mg
egis pharmaceuticals plc, maďarsko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
assubex 2,5 mg
egis pharmaceuticals plc, maďarsko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
bozilos
egis pharmaceuticals plc, maďarsko - teriflunomid - 59 - immunopraeparata
pirfenidone teva 801 mg filmom obalené tablety
teva pharmaceuticals slovakia s.r.o., slovensko - pirfenidón - 59 - immunopraeparata
pirfenidone teva 267 mg filmom obalené tablety
teva pharmaceuticals slovakia s.r.o., slovensko - pirfenidón - 59 - immunopraeparata
xiltess 20 mg
egis pharmaceuticals plc, maďarsko - rivaroxabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)